|
ACE/Angiotension receptors
Citations 91-100 of 225 total displayed.
|
Past content
(since Jun 1999):
|
- Articles
Regulation of Proangiogenic Factor CCN1 in Cardiac Muscle. Impact of Ischemia, Pressure Overload, and Neurohumoral Activation
- Denise Hilfiker-Kleiner, Karol Kaminski, Agnieszka Kaminska, Martin Fuchs, Gunnar Klein, Edith Podewski, Karsten Grote, Ioulia Kiian, Kai C. Wollert, Andres Hilfiker, and Helmut Drexler
Circulation published April 26, 2004, doi:10.1161/01.CIR.0000127952.90508.9D
[Abstract]
- Correspondence
Aldosterone Levels After Angiotensin Receptor Blocker Treatment • Response
- Richard J. Folkeringa, Yigal M. Pinto, Harry J.G.M. Crijns, Jay N. Cohn, Inder S. Anand, Roberto Latini, Serge Masson, Yann-Tong Chiang, and Robert Glazer
Circulation 2004;109:e182, doi:10.1161/01.CIR.0000124885.70372.41
[Full text]
- Basic Science Reports
Irbesartan but Not Amlodipine Suppresses Diabetes-Associated Atherosclerosis
- Riccardo Candido, Terri J. Allen, Markus Lassila, Zemin Cao, Vicki Thallas, Mark E. Cooper, and Karin A. Jandeleit-Dahm
Circulation 2004;109:1536-1542; published online before print as doi:10.1161/01.CIR.0000124061.78478.94
[Abstract]
[Full text]
- Articles
Activation of Matrix Metalloproteinases Precedes Left Ventricular Remodeling in Hypertensive Heart Failure Rats. Its Inhibition as a Primary Effect of Angiotensin-Converting Enzyme Inhibitor
- Yasushi Sakata, Kazuhiro Yamamoto, Toshiaki Mano, Nagahiro Nishikawa, Junichi Yoshida, Masatsugu Hori, Takeshi Miwa, and Tohru Masuyama
Circulation published March 29, 2004, doi:10.1161/01.CIR.0000125741.88712.77
[Abstract]
- Articles
Irbesartan but Not Amlodipine Suppresses Diabetes-Associated Atherosclerosis
- Riccardo Candido, Terri J. Allen, Markus Lassila, Zemin Cao, Vicki Thallas, Mark E. Cooper, and Karin A. Jandeleit-Dahm
Circulation published March 15, 2004, doi:10.1161/01.CIR.0000124061.78478.94
[Abstract]
- Basic Science Reports
C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice
- Antoni Paul, Kerry W.S. Ko, Lan Li, Vijay Yechoor, Mark A. McCrory, Alexander J. Szalai, and Lawrence Chan
Circulation 2004;109:647-655; published online before print as doi:10.1161/01.CIR.0000114526.50618.24
[Abstract]
[Full text]
- Review: Current Perspective
Can Angiotensin II Type 2 Receptors Have Deleterious Effects in Cardiovascular Disease?: Implications for Therapeutic Blockade of the Renin–Angiotensin System
- Bernard I. Lévy
Circulation 2004;109:8-13, doi:10.1161/01.CIR.0000096609.73772.C5
[Full text]
- Basic Science Reports
Coronary Microvascular Endothelial Stunning After Acute Pressure Overload in the Conscious Dog Is Caused by Oxidant Processes: The Role of Angiotensin II Type 1 Receptor and NAD(P)H Oxidase
- Shintaro Kinugawa, Heiner Post, Pawel M. Kaminski, Xiaoping Zhang, Xiaobin Xu, Harer Huang, Fabio A. Recchia, Manuel Ochoa, Michael S. Wolin, Gabor Kaley, and Thomas H. Hintze
Circulation 2003;108:2934-2940; published online before print as doi:10.1161/01.CIR.0000096488.78151.97
[Abstract]
[Full text]
- Articles
Coronary Microvascular Endothelial Stunning After Acute Pressure Overload in the Conscious Dog Is Caused by Oxidant Processes. The Role of Angiotensin II Type 1 Receptor and NAD(P)H Oxidase
- Shintaro Kinugawa, Heiner Post, Pawel M. Kaminski, Xiaoping Zhang, Xiaobin Xu, Harer Huang, Fabio A. Recchia, Manuel Ochoa, Michael S. Wolin, Gabor Kaley, and Thomas H. Hintze
Circulation published December 1, 2003, doi:10.1161/01.CIR.0000096488.78151.97
[Abstract]
- Basic Science Reports
Aldosterone and Not Plasminogen Activator Inhibitor-1 Is a Critical Mediator of Early Angiotensin II/NG-Nitro-l-Arginine Methyl Ester-Induced Myocardial Injury
- Eveline M. Oestreicher, Diego Martinez-Vasquez, James R. Stone, Larus Jonasson, Weranuj Roubsanthisuk, Koji Mukasa, and Gail K. Adler
Circulation 2003;108:2517-2523; published online before print as doi:10.1161/01.CIR.0000097000.51723.6F
[Abstract]
[Full text]
|
|
